Rational drug design and HIV: Hopes and limitations
- 1 June 1995
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 1 (6) , 519-520
- https://doi.org/10.1038/nm0695-519
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High resolution structures of HIV-1 RT from four RT–inhibitor complexesNature Structural & Molecular Biology, 1995
- Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitorsNature Structural & Molecular Biology, 1995
- Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 å resolutionStructure, 1995
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside InhibitorsScience, 1995
- The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.Proceedings of the National Academy of Sciences, 1995
- Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.Proceedings of the National Academy of Sciences, 1994
- Inhibitors of Aspartyl ProteinasesMedicinal Research Reviews, 1993
- Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.Proceedings of the National Academy of Sciences, 1993
- Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an InhibitorScience, 1992
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990